Table 1 Study sites, study teams and numbers of villages screened in the eligibility surveys
Type of study | Country | Region of the country | Lead African partner institution | Lead Northern partner institution | # villages screened | # (%) villages that met criteria |
|---|---|---|---|---|---|---|
Sustaining control | Côte d’Ivoire (Sm1) | Région des Montagnes and Région du Moyen Cavally | Université Félix Houphouët-Boigny; Abidjan, Côte d’Ivoire | Swiss Tropical and Public Health Institute; Basel, Switzerland | 263 | 77 (29.3) |
Kenya (Sm1) | Kisumu region in western Kenya bordering Lake Victoria | Center for Global Health Research, Kenya Medical Research Institute (KEMRI); Nairobi, Kenya | Centers for Disease Control and Prevention (CDC); Atlanta, USA | 150 | 75 (50.0) | |
Niger (Sh1) | Dosso and Tillaberi regions in western Niger | Réseau International Schistosomoses, Environnement, Aménagement et Lutte (RISEAL-Niger), Niamey, Niger | Schistosomiasis Control Initiative (SCI), Imperial College London; London, UK | 150 | 75 (50.0) | |
Gaining control | Kenya (Sm2) | Kisumu region in western Kenya bordering Lake Victoria | Center for Global Health Research, KEMRI; Nairobi, Kenya | CDC; Atlanta, USA | 320 | 150 (46.9) |
Mozambique (Sh2) | Cabo Delgado province in northern Mozambique | Catholic University of Mozambique; Beira, Mozambique | SCI, Imperial College London; London, UK | 150 | 150 (100.0) | |
Niger (Sh2) | Dosso and Tillaberi regions in western Niger | National NTD Programme, Ministry of Health, Niamey, Niger | SCI, Imperial College London; London, UK | 248 | 150 (60.5) | |
Tanzania (Sm2) | Mwanza region bordering Lake Victoria | Mwanza Research Center, National Institute for Medical Research (NIMR); Mwanza, Tanzania | University of Copenhagen; Copenhagen, Denmark | 308 | 167 (50.9) | |
Total | 1,569 | 767 (48.3) |